Rheumatoid Arthritis

We have recently spun out a company, OsteoRx Ltd, and a project in which we discovered novel therapies for rheumatoid arthritis, is being commercialised by Modern Biosciences

In a field dominated by expensive biological agents, we discovered a series of small molecule inhibitors which have therapeutic potential for the treatment of a number of inflammatory and autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease and psoriasis.

Funding: Knowledge Transfer Grant (2001), Scottish Enterprise Proof of Concept (2002), Royal Society of Edinburgh Enterprise Fellowship (2003), Scottish Enterprise Proof of Concept Follow-on (2005), Arthritis and Rheumatism Campaign (2005), NESTech (2006), Modern Biosciences (2008)

Project Team: Dr Iain Greig